We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current LLY market cap is 738.43B. The company's latest EPS is USD 11.1689 and P/E is 74.99.
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 24.56B | 28.32B | 28.54B | 34.12B | 45.04B |
| Operating Income | 6.06B | 6.66B | 7.37B | 6.46B | 13.32B |
| Net Income | 6.19B | 5.58B | 6.24B | 5.24B | 10.59B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 46.63B | 48.81B | 49.49B | 64.01B | 78.71B |
| Total Liabilities | 40.81B | 39.65B | 38.71B | 53.14B | 64.44B |
| Total Equity | 5.83B | 9.15B | 10.78B | 10.86B | 14.27B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 6.5B | 7.26B | 7.08B | 4.24B | 8.82B |
| Investing | -2.26B | -2.76B | -3.26B | -7.15B | -9.3B |
| Financing | -3.14B | -4.13B | -5.41B | 3.5B | 1.23B |
| Market Cap | 738.43B |
| Price to Earnings Ratio | 74.99 |
| Price to Sales Ratio | 17.63 |
| Price to Cash Ratio | 242.98 |
| Price to Book Ratio | 55.65 |
| Dividend Yield | 0.84% |
| Shares Outstanding | 948.17M |
| Average Volume (1 week) | 1.91k |
| Average Volume (1 Month) | 3.59k |
| 52 Week Change | 9.00% |
| 52 Week High | 891.00 |
| 52 Week Low | 40.43 |
| Spread (Intraday) | 1.1 (0.14%) |
| Company Name | Lilly Eli and Co |
| Address |
334 north senate avenue indianapolis, indiana 46204 |
| Website | https://www.lilly.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
